Data Foundry

Drug recalls 2013

Exforge — Class II drug recall D-334-2014

Terminated recall by Novartis Pharmaceuticals Corp., reported 2013-12-18, distributed nationwide. Chemical Contamination: Novartis Pharmaceuticals Corporation has recalled physician sample bottles of Diovan,

Recall numberD-334-2014
Product typeDrug
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmNovartis Pharmaceuticals Corp., Suffern, NY, United States
Recall initiated2013-08-08
Classified2013-12-06
Reported by FDA2013-12-18
Terminated2015-12-21
DistributedNationwide (US)
Quantity951,109 bottles
Reason classeschemical contamination
NDC00078-9491-07
Lot numbersF0131, F0137, F0138, F0139, F0140, F0141, F0142, F0142A, F0145, F0150, F0157, F0158, F0159, F0160, F0163, F0165, F0184
Expiration dates2013-11-30, 2014-01-31, 2014-02-28, 2014-04-30, 2014-05-31, 2014-07-31, 2015-01-31

Product

Exforge (amlodipine and valsartan, Tablets) 10/320 mg, Rx only, 7 tablets per bottle, Physician Sample - Not For Sale. Manufactured by: Novartis Pharma Stein AG Stein, Switzerland. Distributed by: Novartis Pharmaceuticals Corp. East Hanover, New Jersey 07936, NDC # 0078-9491-07

Reason for recall

Chemical Contamination: Novartis Pharmaceuticals Corporation has recalled physician sample bottles of Diovan, Exforge, Exforge HCT,Lescol XL, Stalevo, Tekturna and Tekturna HCT Tablets due to contamination with Darocur 1173 a photocuring agent used in inks on shrink-wrap sleeves.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-334-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.